AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|AAPL346.04+2.05 (+0.60%) ▲|ABBV284.56-0.24 (-0.09%) ▼|ABT102.44+1.93 (+1.92%) ▲|ACN251.79+11.53 (+4.80%) ▲|ADBE269.35+14.29 (+5.60%) ▲|AMAT379.67-29.27 (-7.16%) ▼|AMD510.23-42.50 (-7.69%) ▼|AMGN448.43+10.09 (+2.30%) ▲|AMT180.83+3.19 (+1.80%) ▲|AMZN250.25-12.13 (-4.62%) ▼|AVGO324.69-13.11 (-3.88%) ▼|AXP324.15+0.54 (+0.17%) ▲|BA188.42-3.86 (-2.01%) ▼|BAC50.92+0.14 (+0.28%) ▲|BKNG161.73+3.35 (+2.12%) ▲|BLK1,140.28-9.32 (-0.81%) ▼|BMY63.40+2.28 (+3.73%) ▲|BNY144.39-1.47 (-1.00%) ▼|BRK-B549.50+10.51 (+1.95%) ▲|C122.00-1.85 (-1.49%) ▼|CAT700.46-39.75 (-5.37%) ▼|CL97.26+3.86 (+4.13%) ▲|CMCSA22.72+0.64 (+2.91%) ▲|COF203.62-3.05 (-1.47%) ▼|COP146.03+0.36 (+0.25%) ▲|COST1,013.81+15.50 (+1.55%) ▲|CRM249.84+8.06 (+3.33%) ▲|CSCO104.94-2.33 (-2.17%) ▼|CVS94.12+1.34 (+1.44%) ▲|CVX226.22-0.57 (-0.25%) ▼|DE639.41+2.87 (+0.45%) ▲|DHR229.92-3.94 (-1.69%) ▼|DIS112.61+0.78 (+0.70%) ▲|DUK124.83+4.16 (+3.45%) ▲|EMR158.07-5.04 (-3.09%) ▼|FDX302.92+4.69 (+1.57%) ▲|GD348.39+3.68 (+1.07%) ▲|GE290.18-5.70 (-1.93%) ▼|GEV822.47-103.45 (-11.17%) ▼|GILD156.80+3.23 (+2.10%) ▲|GM76.72+0.61 (+0.79%) ▲|GOOG320.83-10.12 (-3.06%) ▼|GOOGL324.44-10.33 (-3.08%) ▼|GS887.73-16.99 (-1.88%) ▼|HD325.72+11.58 (+3.69%) ▲|HON215.32+0.59 (+0.27%) ▲|IBM249.87-1.59 (-0.63%) ▼|INTC86.11-6.85 (-7.37%) ▼|INTU353.97+18.36 (+5.47%) ▲|ISRG441.26+13.14 (+3.07%) ▲|JNJ268.91+11.13 (+4.32%) ▲|JPM334.80-0.39 (-0.12%) ▼|KO94.84+2.16 (+2.33%) ▲|LIN509.77+9.20 (+1.84%) ▲|LLY1,311.52+40.77 (+3.21%) ▲|LMT585.45+33.94 (+6.15%) ▲|LOW203.10+6.54 (+3.33%) ▲|LRCX231.69-29.12 (-11.17%) ▼|MA631.79+9.17 (+1.47%) ▲|MCD251.63+5.38 (+2.18%) ▲|MDLZ64.91+2.17 (+3.45%) ▲|MDT95.58+2.55 (+2.74%) ▲|META645.44-52.08 (-7.47%) ▼|MMM174.08-0.66 (-0.38%) ▼|MO75.86+2.03 (+2.74%) ▲|MRK147.96-1.92 (-1.28%) ▼|MS183.29-3.73 (-1.99%) ▼|MSFT523.97-8.98 (-1.69%) ▼|MU860.14-53.53 (-5.86%) ▼|NEE81.39+3.11 (+3.97%) ▲|NFLX67.22+2.18 (+3.35%) ▲|NKE38.27+0.74 (+1.96%) ▲|NOW156.69+3.57 (+2.33%) ▲|NVDA212.50-9.47 (-4.27%) ▼|ORCL123.41-5.72 (-4.43%) ▼|PEP138.27+3.57 (+2.65%) ▲|PFE30.25+0.40 (+1.34%) ▲|PG166.12+9.28 (+5.92%) ▲|PLTR197.07-4.65 (-2.31%) ▼|PM200.87+3.41 (+1.73%) ▲|QCOM172.75-5.22 (-2.93%) ▼|RTX192.53+0.93 (+0.49%) ▲|SBUX101.62+2.54 (+2.56%) ▲|SCHW92.21+0.57 (+0.62%) ▲|SO93.28+2.89 (+3.20%) ▲|SPG211.18+5.63 (+2.74%) ▲|T22.68+0.77 (+3.49%) ▲|TMO676.83-17.19 (-2.48%) ▼|TMUS158.27+4.52 (+2.94%) ▲|TSLA377.95-8.53 (-2.21%) ▼|TXN283.23-1.42 (-0.50%) ▼|UBER68.21+0.59 (+0.87%) ▲|UNH424.60+7.60 (+1.82%) ▲|UNP296.04+8.17 (+2.84%) ▲|UPS101.69+2.12 (+2.12%) ▲|USB59.91+0.86 (+1.45%) ▲|V413.95+6.10 (+1.50%) ▲|VZ44.80+1.24 (+2.84%) ▲|WFC83.02+0.60 (+0.73%) ▲|WMT120.45+2.65 (+2.25%) ▲|XOM177.34-0.75 (-0.42%) ▼|
19.5 C
New York
Thursday, October 22, 2026

Tag: action

newsFORsourcecompanycontentinformation1releasesmarket

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages iRobot Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRBT

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and March 11, 2025, both dates inclusive (the “Class Period”), of the important September 5, 2025 lead plaintiff deadline.

Ozak AI Presale Rockets to $1.6M, Over 90 Million $OZ Tokens Already Sold Out

ROAD TOWN, British Virgin Islands, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Ozak AI’s growth is showing no signs of slowing down, with the project now surpassing $1.6 million in total funds raised. Over 90 million $OZ tokens have already been sold out, demonstrating the surging demand from crypto investors keen to gain exposure to one of the most talked-about AI-driven crypto initiatives this year.

RDDT FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Reddit, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August...

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

Aaron Fraser Marks 5 Years of The Action Sports Club with #1 International Best-Selling Sponsorship Guide

The Modern Playbook for Sponsorship and Cash Flow helps athletes get sponsored, grow their brand, and turn passion into profit. Kelowna, BC, Aug. 9, 2025...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. – GRPN

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. – AGL

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. – INSP

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. – ALT

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Altimmune, Inc.  (“Altimmune” or the “Company”) (NASDAQ: ALT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. – DBI

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Designer Brands Inc.  (“Designer Brands” or the “Company”) (NYSE: DBI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE – ARGX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. – DYN

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. – EWTX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. – KBR

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc.  (“KBR” or the “Company”) (NYSE: KBR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAction

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers